Cummings: Drug Pricing Bills Won't Move This Year

Legislation addressing drug pricing is likely going to have to wait until the next session of Congress, according to House oversight committee ranking Democrat Elijah Cummings (MD), following a multi-hour hearing where lawmakers grilled Mylan CEO Heather Bresch on the cost of EpiPens. “I think it's going to be hard to get anything done. I think it would have to be pushed into the next session,” Cummings told Inside Health Policy . “I try to be optimistic, but I think...